Riboregulators in kidney development and function

Biochimie

Volumn 92, Issue 3, 2010, Pages 217-225

  Karolina, Dwi Setyowati ^a   Wintour, E M ^b   Bertram, John ^b   Jeyaseelan, Kandiah ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Diseases; Function; MicroRNA; Renal development; RNAi

Indexed keywords

ALPHA TROPOMYOSIN; ANGIOTENSIN 1 RECEPTOR; CYCLIN DEPENDENT KINASE 3; EXPORTIN 5; HIGH MOBILITY GROUP A2 PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; MASPIN; MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; RAS PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1;

BIOGENESIS; CENTRAL NERVOUS SYSTEM DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DNA MICROARRAY; DOWN REGULATION; ENZYME INHIBITION; GENE ACTIVATION; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC DISORDER; GLOMERULONEPHRITIS; HEART DISEASE; HUMAN; HYPERTENSION; INSULIN RELEASE; INSULIN SYNTHESIS; KIDNEY CANCER; KIDNEY DEVELOPMENT; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LIVER POLYCYSTIC DISEASE; LUPUS ERYTHEMATOSUS NEPHRITIS; NONHUMAN; REPRESSOR GENE; REVIEW; UPREGULATION;

ANIMALS; GENE KNOCKDOWN TECHNIQUES; HUMANS; KIDNEY; KIDNEY DISEASES; MICRORNAS;

EID: 77649273049     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2009.12.008     Document Type: Review

References (112)

1. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
2. Shcherbata H.R., Hatfield S., Ward E.J., Reynolds S., Fischer K.A., Ruohola-Baker H. The microRNA pathway plays a regulatory role in stem cell division. Cell Cycle 2006, 5:172-175.
3. Shivdasani R.A. MicroRNAs: regulators of gene expression and cell differentiation. Blood 2006, 108:3646-3653.
4. Esau C., Davis S., Murray S.F., Yu X.X., Pandey S.K., Pear M., Watts L., Booten S.L., Graham M., McKay R., Subramaniam A., Propp S., Lollo B.A., Freier S., Bennett C.F., Bhanot S., Monia B.P. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006, 3:87-98.
5. Kuhn D.E., Nuovo G.J., Martin M.M., Malana G.E., Pleister A.P., Jiang J., Schmittgen T.D., Terry A.V., Gardiner K., Head E., Feldman D.S., Elton T.S. Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. Biochem. Biophys. Res. Commun. 2008, 370:473-477.
6. Li Y., Lin L., Jin P. The microRNA pathway and fragile X mental retardation protein. Biochim. Biophys. Acta 2008.
7. Alvarez-Garcia I., Miska E.A. MicroRNA functions in animal development and human disease. Development 2005, 132:4653-4662.
8. Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., Horvitz H.R., Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
9. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 2005, 6:376-385.
10. Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004, 14:1902-1910.
11. Farh K.K., Grimson A., Jan C., Lewis B.P., Johnston W.K., Lim L.P., Burge C.B., Bartel D.P. The widespread impact of mammalian microRNAs on mRNA repression and evolution,. Science 2005, 310:1817-1821.
12. Borchert G.M., Lanier W., Davidson B.L. RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 2006, 13:1097-1101.
13. Khvorova A., Reynolds A., Jayasena S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115:209-216.
14. Gregory R.I., Chendrimada T.P., Cooch N., Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123:631-640.
15. Valencia-Sanchez M.A., Liu J., Hannon G.J., Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006, 20:515-524.
16. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
17. Li L.C., Okino S.T., Zhao H., Pookot D., Place R.F., Urakami S., Enokida H., Dahiya R. Small dsRNAs induce transcriptional activation in human cells. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17337-17342.
18. Janowski B.A., Younger S.T., Hardy D.B., Ram R., Huffman K.E., Corey D.R. Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat. Chem. Biol. 2007, 3:166-173.
19. Place R.F., Li L.C., Pookot D., Noonan E.J., Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:1608-1613.
20. Fazi F., Rosa A., Fatica A., Gelmetti V., De Marchis M.L., Nervi C., Bozzoni I. A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 2005, 123:819-831.
21. Ramkissoon S.H., Mainwaring L.A., Ogasawara Y., Keyvanfar K., McCoy J.P., Sloand E.M., Kajigaya S., Young N.S. Hematopoietic-specific microRNA expression in human cells. Leuk. Res. 2006, 30:643-647.
22. Chen J.F., Mandel E.M., Thomson J.M., Wu Q., Callis T.E., Hammond S.M., Conlon F.L., Wang D.Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation,. Nat. Genet. 2006, 38:228-233.
23. Zhao Y., Samal E., Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436:214-220.
24. Houbaviy H.B., Murray M.F., Sharp P.A. Embryonic stem cell-specific microRNAs. Dev. Cell 2003, 5:351-358.
25. Poy M.N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P.E., Pfeffer S., Tuschl T., Rajewsky N., Rorsman P., Stoffel M. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004, 432:226-230.
26. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., Iorio M.V., Visone R., Sever N.I., Fabbri M., Iuliano R., Palumbo T., Pichiorri F., Roldo C., Garzon R., Sevignani C., Rassenti L., Alder H., Volinia S., Liu C.G., Kipps T.J., Negrini M., Croce C.M. A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia,. N. Engl. J. Med. 2005, 353:1793-1801.
27. Williams A.E., Moschos S.A., Perry M.M., Barnes P.J., Lindsay M.A. Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev. Dyn. 2007, 236:572-580.
28. Mattes J., Whitehead B., Liehr T., Wilkinson I., Bear J., Fagan K., Craven P., Bennetts B., Edwards M. Paternal uniparental isodisomy for chromosome 14 with mosaicism for a supernumerary marker chromosome 14. Am. J. Med. Genet. A 2007, 143A:2165-2171.
29. Human Embryology and Developmental Biology 2004, Mosby, Saint Louis. B.M. Carlson (Ed.).
30. Massry and Glassock's Textbook of Nephrology 2001, Lippincott Williams & Wilkins, Philadelphia. fourth ed. S. Massry (Ed.).
31. Gomez R.A., Sequeira Lopez M.L., Fernandez L., Chernavvsky D.R., Norwood V.F. The maturing kidney: development and susceptibility,. Ren. Fail. 1999, 21:283-291.
32. Solhaug M.J., Bolger P.M., Jose P.A. The developing kidney and environmental toxins. Pediatrics 2004, 113:1084-1091.
33. Sweet D.H., Bush K.T., Nigam S.K. The organic anion transporter family: from physiology to ontogeny and the clinic. Am. J. Physiol. Ren. Physiol. 2001, 281:F197-F205.
34. Zhang L., Brett C.M., Giacomini K.M. Role of organic cation transporters in drug absorption and elimination. Annu. Rev. Pharmacol. Toxicol. 1998, 38:431-460.
35. Larsson S.H., Aperia A. Renal growth in infancy and childhood - experimental studies of regulatory mechanisms. Pediatr. Nephrol. 1991, 5:439-442.
36. Celsi G., Jakobsson B., Aperia A. Influence of age on compensatory renal growth in rats. Pediatr. Res. 1986, 20:347-350.
37. Landgraf P., Rusu M., Sheridan R., Sewer A., Iovino N., Aravin A., Pfeffer S., Rice A., Kamphorst A.O., Landthaler M., Lin C., Socci N.D., Hermida L., Fulci V., Chiaretti S., Foa R., Schliwka J., Fuchs U., Novosel A., Muller R.U., Schermer B., Bissels U., Inman J., Phan Q., Chien M., Weir D.B., Choksi R., De Vita G., Frezzetti D., Trompeter H.I., Hornung V., Teng G., Hartmann G., Palkovits M., Di Lauro R., Wernet P., Macino G., Rogler C.E., Nagle J.W., Ju J., Papavasiliou F.N., Benzing T., Lichter P., Tam W., Brownstein M.J., Bosio A., Borkhardt A., Russo J.J., Sander C., Zavolan M., Tuschl T. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 2007, 129:1401-1414.
38. Sun Y., Koo S., White N., Peralta E., Esau C., Dean N.M., Perera R.J. Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs. Nucleic Acids Res. 2004, 32:e188.
39. Baskerville S., Bartel D.P. Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA (New York, N.Y.) 2005, 11:241-247.
40. Harvey S.J., Jarad G., Cunningham J., Goldberg S., Schermer B., Harfe B.D., McManus M.T., Benzing T., Miner J.H. Podocyte-specific deletion of dicer alters cytoskeletal dynamics and causes glomerular disease. J. Am. Soc. Nephrol. 2008, 19:2150-2158.
41. Ho J., Ng K.H., Rosen S., Dostal A., Gregory R.I., Kreidberg J.A. Podocyte-specific loss of functional microRNAs leads to rapid glomerular and tubular injury. J. Am. Soc. Nephrol. 2008, 19:2069-2075.
42. Shi S., Yu L., Chiu C., Sun Y., Chen J., Khitrov G., Merkenschlager M., Holzman L.B., Zhang W., Mundel P., Bottinger E.P. Podocyte-selective deletion of dicer induces proteinuria and glomerulosclerosis. J. Am. Soc. Nephrol. 2008, 19:2159-2169.
43. Gottardo F., Liu C.G., Ferracin M., Calin G.A., Fassan M., Bassi P., Sevignani C., Byrne D., Negrini M., Pagano F., Gomella L.G., Croce C.M., Baffa R. Micro-RNA profiling in kidney and bladder cancers. Urol. Oncol. 2007, 25:387-392.
44. Perdomo J., Holmes M., Chong B., Crossley M. Eos and pegasus, two members of the Ikaros family of proteins with distinct DNA binding activities. J. Biol. Chem. 2000, 275:38347-38354.
45. Takamizawa J., Konishi H., Yanagisawa K., Tomida S., Osada H., Endoh H., Harano T., Yatabe Y., Nagino M., Nimura Y., Mitsudomi T., Takahashi T. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004, 64:3753-3756.
46. Kort E.J., Farber L., Tretiakova M., Petillo D., Furge K.A., Yang X.J., Cornelius A., Teh B.T. The E2F3-Oncomir-1 axis is activated in Wilms' tumor. Cancer Res. 2008, 68:4034-4038.
47. Woods K., Thomson J.M., Hammond S.M. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J. Biol. Chem. 2007, 282:2130-2134.
48. Tahvanainen E., Tahvanainen P., Kaariainen H., Hockerstedt K. Polycystic liver and kidney diseases. Ann. Med. 2005, 37:546-555.
49. Torres V.E., Harris P.C. Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases. Nat. Clin. Pract. Nephrol. 2006, 2:40-55. quiz 55.
50. Ibraghimov-Beskrovnaya O., Bukanov N. Polycystic kidney diseases: from molecular discoveries to targeted therapeutic strategies. Cell Mol. Life Sci. 2008, 65:605-619.
51. Lee S.O., Masyuk T., Splinter P., Banales J.M., Masyuk A., Stroope A., Larusso N. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J. Clin. Invest. 2008, 118:3714-3724.
52. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008, 18:350-359.
53. Chu A.S., Friedman J.R. A role for microRNA in cystic liver and kidney diseases. J. Clin. Invest. 2008, 118:3585-3587.
54. Dai Y., Sui W., Lan H., Yan Q., Huang H., Huang Y. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol. Int. 2009, 29:749-754.
55. Dai Y., Sui W., Lan H., Yan Q., Huang H., Huang Y. Microarray analysis of micro-ribonucleic acid expression in primary immunoglobulin A nephropathy. Saudi Med. J. 2008, 29:1388-1393.
56. Anglicheau D., Sharma V.K., Ding R., Hummel A., Snopkowski C., Dadhania D., Seshan S.V., Suthanthiran M. MicroRNA expression profiles predictive of human renal allograft status. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5330-5335.
57. Tang X., Tang G., Ozcan S. Role of microRNAs in diabetes. Biochim. Biophys. Acta 2008, 1179:697-701.
58. Gauthier B.R., Wollheim C.B. MicroRNAs: 'ribo-regulators' of glucose homeostasis. Nat. Med. 2006, 12:36-38.
59. Baroukh N., Ravier M.A., Loder M.K., Hill E.V., Bounacer A., Scharfmann R., Rutter G.A., Van Obberghen E. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. J. Biol. Chem. 2007, 282:19575-19588.
60. Lovis P., Gattesco S., Regazzi R. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biol. Chem. 2008, 389:305-312.
61. Plaisance V., Abderrahmani A., Perret-Menoud V., Jacquemin P., Lemaigre F., Regazzi R. MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells. J. Biol. Chem. 2006, 281:26932-26942.
62. Torii S., Takeuchi T., Nagamatsu S., Izumi T. Rab27 effector granuphilin promotes the plasma membrane targeting of insulin granules via interaction with syntaxin 1a. J. Biol. Chem. 2004, 279:22532-22538.
63. Kato M., Zhang J., Wang M., Lanting L., Yuan H., Rossi J.J., Natarajan R. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:3432-3437.
64. Wang Q., Wang Y., Minto A.W., Wang J., Shi Q., Li X., Quigg R.J. MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J. 2008, 22:4126-4135.
65. van Geel P.P., Pinto Y.M., Voors A.A., Buikema H., Oosterga M., Crijns H.J., van Gilst W.H. Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension 2000, 35:717-721.
66. Carswell C.I., Goa K.L. Losartan in diabetic nephropathy. Drugs 2003, 63:407-414. discussion, 415-406.
67. Burnier M., Brunner H.R. Angiotensin II receptor antagonists. Lancet 2000, 355:637-645.
68. Sethupathy P., Collins F.S. MicroRNA target site polymorphisms and human disease. Trends Genet. 2008, 24:489-497.
69. Lund E., Guttinger S., Calado A., Dahlberg J.E., Kutay U. Nuclear export of microRNA precursors. Science 2004, 303:95-98.
70. Soifer H.S., Rossi J.J., Saetrom P. MicroRNAs in disease and potential therapeutic applications. Mol. Ther. 2007, 15:2070-2079.
71. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Radmark O., Kim S., Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
72. Yi R., Qin Y., Macara I.G., Cullen B.R. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17:3011-3016.
73. Orom U.A., Kauppinen S., Lund A.H. LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 2006, 372:137-141.
74. Allerson C.R., Sioufi N., Jarres R., Prakash T.P., Naik N., Berdeja A., Wanders L., Griffey R.H., Swayze E.E., Bhat B. Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J. Med. Chem. 2005, 48:901-904.
75. Prakash T.P., Allerson C.R., Dande P., Vickers T.A., Sioufi N., Jarres R., Baker B.F., Swayze E.E., Griffey R.H., Bhat B. Positional effect of chemical modifications on short interference RNA activity in mammalian cells. J. Med. Chem. 2005, 48:4247-4253.
76. Czauderna F., Fechtner M., Dames S., Aygun H., Klippel A., Pronk G.J., Giese K., Kaufmann J. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res. 2003, 31:2705-2716.
77. Chiu Y.L., Rana T.M. siRNA function in RNAi: a chemical modification analysis. RNA (New York, N.Y.) 2003, 9:1034-1048.
78. Bijsterbosch M.K., Rump E.T., De Vrueh R.L., Dorland R., van Veghel R., Tivel K.L., Biessen E.A., van Berkel T.J., Manoharan M. Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation. Nucleic Acids Res. 2000, 28:2717-2725.
79. Harborth J., Elbashir S.M., Vandenburgh K., Manninga H., Scaringe S.A., Weber K., Tuschl T. Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. Antisense Nucleic Acid Drug Dev. 2003, 13:83-105.
80. Layzer J.M., McCaffrey A.P., Tanner A.K., Huang Z., Kay M.A., Sullenger B.A. In vivo activity of nuclease-resistant siRNAs. RNA (New York, N.Y.) 2004, 10:766-771.
81. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
82. Ebert M.S., Neilson J.R., Sharp P.A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 2007, 4:721-726.
83. Care A., Catalucci D., Felicetti F., Bonci D., Addario A., Gallo P., Bang M.L., Segnalini P., Gu Y., Dalton N.D., Elia L., Latronico M.V., Hoydal M., Autore C., Russo M.A., Dorn G.W., Ellingsen O., Ruiz-Lozano P., Peterson K.L., Croce C.M., Peschle C., Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 2007, 13:613-618.
84. Esau C.C., Monia B.P. Therapeutic potential for microRNAs. Adv. Drug Deliv. Rev. 2007, 59:101-114.
85. Doench J.G., Petersen C.P., Sharp P.A. siRNAs can function as miRNAs. Genes Dev. 2003, 17:438-442.
86. Takabatake Y., Isaka Y., Mizui M., Kawachi H., Shimizu F., Ito T., Hori M., Imai E. Exploring RNA interference as a therapeutic strategy for renal disease. Gene Ther. 2005, 12:965-973.
87. Takabatake Y., Isaka Y., Mizui M., Kawachi H., Takahara S., Imai E. Chemically modified siRNA prolonged RNA interference in renal disease. Biochem. Biophys. Res. Commun. 2007, 363:432-437.
88. Miyagishi M., Taira K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat. Biotechnol. 2002, 20:497-500.
89. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296:550-553.
90. Grimm D., Streetz K.L., Jopling C.L., Storm T.A., Pandey K., Davis C.R., Marion P., Salazar F., Kay M.A. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006, 441:537-541.
91. McManus M.T., Petersen C.P., Haines B.B., Chen J., Sharp P.A. Gene silencing using micro-RNA designed hairpins. RNA (New York, N.Y.) 2002, 8:842-850.
92. Castanotto D., Sakurai K., Lingeman R., Li H., Shively L., Aagaard L., Soifer H., Gatignol A., Riggs A., Rossi J.J. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC. Nucleic Acids Res. 2007, 35:5154-5164.
93. Dickins R.A., McJunkin K., Hernando E., Premsrirut P.K., Krizhanovsky V., Burgess D.J., Kim S.Y., Cordon-Cardo C., Zender L., Hannon G.J., Lowe S.W. Tissue-specific and reversible RNA interference in transgenic mice. Nat. Genet. 2007, 39:914-921.
94. McBride J.L., Boudreau R.L., Harper S.Q., Staber P.D., Monteys A.M., Martins I., Gilmore B.L., Burstein H., Peluso R.W., Polisky B., Carter B.J., Davidson B.L. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:5868-5873.
95. Zhang B., Pan X., Cobb G.P., Anderson T.A. Plant microRNA: a small regulatory molecule with big impact. Dev. Biol. 2006, 289:3-16.
96. Liu Z., Sall A., Yang D. MicroRNAs: an emerging therapeutic target and intervention tool. Int. J. Mol. Sci. 2008, 9:978-999.
97. Aagaard L., Amarzguioui M., Sun G., Santos L.C., Ehsani A., Prydz H., Rossi J.J. A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha. Mol. Ther. 2007, 15:938-945.
98. Liang Z., Wu H., Reddy S., Zhu A., Wang S., Blevins D., Yoon Y., Zhang Y., Shim H. Blockade of invasion and metastasis of breast cancer cells via targeting CXCR4 with an artificial microRNA. Biochem. Biophys. Res. Commun. 2007, 363:542-546.
99. Scaria V., Hariharan M., Brahmachari S.K., Maiti S., Pillai B. microRNA: an emerging therapeutic. ChemMedChem 2007, 2:789-792.
100. Hennessy E., O'Driscoll L. Molecular medicine of microRNAs: structure, function and implications for diabetes. Expert Rev. Mol. Med. 2008, 10:e24.
101. Calin G.A., Liu C.G., Sevignani C., Ferracin M., Felli N., Dumitru C.D., Shimizu M., Cimmino A., Zupo S., Dono M., Dell'Aquila M.L., Alder H., Rassenti L., Kipps T.J., Bullrich F., Negrini M., Croce C.M. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:11755-11760.
102. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2999-3004.
103. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
104. Lee Y.S., Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007, 21:1025-1030.
105. Pichiorri F., Suh S.S., Ladetto M., Kuehl M., Palumbo T., Drandi D., Taccioli C., Zanesi N., Alder H., Hagan J.P., Munker R., Volinia S., Boccadoro M., Garzon R., Palumbo A., Aqeilan R.I., Croce C.M. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:12885-12890.
106. Liu Q., Fu H., Sun F., Zhang H., Tie Y., Zhu J., Xing R., Sun Z., Zheng X. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res. 2008, 36:5391-5404.
107. Yang B., Lin H., Xiao J., Lu Y., Luo X., Li B., Zhang Y., Xu C., Bai Y., Wang H., Chen G., Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat. Med. 2007, 13:486-491.
108. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure,. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:18255-18260.
109. Cheng Y., Ji R., Yue J., Yang J., Liu X., Chen H., Dean D.B., Zhang C. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy?. Am. J. Pathol. 2007, 170:1831-1840.
110. Hebert S.S., Horre K., Nicolai L., Papadopoulou A.S., Mandemakers W., Silahtaroglu A.N., Kauppinen S., Delacourte A., De Strooper B. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6415-6420.
111. Wang G., van der Walt J.M., Mayhew G., Li Y.J., Zuchner S., Scott W.K., Martin E.R., Vance J.M. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. Am. J. Hum. Genet. 2008, 82:283-289.
112. Pezzolesi M.G., Platzer P., Waite K.A., Eng C. Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. Am. J. Hum. Genet. 2008, 82:1141-1149.